-/-MEFs. Nuclei were counterstained with DAPI. -/-and wild-type MEFs after high LET xenon ions irradiation at the beamline microscope. GFP-aprataxin was rapidly recruited to sites of DNA damage within ~1 min after heavy ion irradiation in Mdc1 +/+ and Mdc1 -/-MEFs.
Fig S2. Recruitment of GFP-MDC1 to heavy ion-induced DSB in Mdc1
-/-MEFs. DNA breaks are revealed by immunostaining for H2AX. Irradiation was carried out with xenon ions (4.5 MeV/u; LET 8815 keV/ m). Nuclei were counterstained with ToPro3.
Fig S4. No recruitment of aprataxin to DNA breaks induced by heavy ion irradiation in XRCC1-deficient CHO cells. A.
Recruitment of GFP-XRCC1 to sites DNA DSBs after high LET uranium ions irradiation (4.2 MeV/u; LET 14925 keV/ m) in wild-type MEFs. B. Absence of GFP-aprataxin recruitment in XRCC1-deficient (EM9) cells after irradiation with uranium ions (4.2 MeV/u; LET 14925 keV/ m). As previously observed in Gueven et al. 2004 , Becherel et al. 2006 , and Hirano et al. 2007 , aprataxin is nuclear and present in both nucleoplasm and nucleoli. C. Recruitment of DsRed-aprataxin to DNA breaks after samarium ions irradiation (4.2 MeV/u; LET 10290 keV/ m) in EM9 cells complemented with GFP-XRCC1. Sites of DNA breaks are detected by H2AX immunostaining and nuclei were counterstained with ToPro3. Fig S5. Effect of Ethidium bromide on the interaction between aprataxin and MDC1. Increasing amounts of Ethidium bromide (EtBr) were added to HeLa total cells extracts, and GST pull downs were performed. EtBr did not disrupt the interaction between aprataxin and MDC1 supporting a direct protein-protein interaction between the two proteins.
Fig S6.
In vivo inhibition of CK2 activity by DMAT. HeLa cells were treated with increasing amounts of DMAT, a CK2-specific inhibitor, for 8 hours and subsequently lysed. Aprataxin FHA pull-downs were performed as described previously and binding of MDC1 was revealed by immunoblotting. Position of CK2 phosphorylation sites as defined by the consensus target sequence (xS/T-x-xD/E-x) using the Group-Based Phosphorylation Scoring Method (GPS) online prediction software in the MDC1 protein sequence (http://bioinformatics.lcdustc.org/gps_web/predict.php) (Xu et al., 2005; Fengfeng et al., 2004) . Analysis was performed using selected kinase (CK2) and high specificity (cut off = 4). Red arrows show predicted phosphorylations sites with a high score (> 5). Phosphorylation sites indicated in the margin in the right of the tables correspond to experimentally identified sites by global mass spectrometry studies (Beausoleil et al., 2004; Olsen et al., 2006) . Stars on the left represent aparatxin FHA preferred binding sites (pS-DpT-D) where pS and pT represent the CK2-phosphorylated residues. H2AX foci repair kinetic after H 2 O 2 treatment (1 mM, 10 min exposure). AOA1 fibroblasts (FD105hTERT) were transfected with either GFP-aprataxin (wild-type) or GFP-aprataxin (R29A) mutant. Untransfected cells were used as control. DSB repair kinetics were similar regardless the presence of absence of aprataxin indicating it is not required for the repair of H 2 O 2 -induced DSB. Aprataxin and MDC1 GST pull down assays. The GST, GST-FHA, GST-NL, GST-HIT, GST-ZF corresponding to aprataxin and GST-150-350 fusion protein corresponding to MDC1 were expressed in E. coli BL21 and bound to glutathione Sepharose beads (Amersham) as recommended by the manufacturer. Total cell extracts were prepared by lysing 5 x 10 6 control cells (HeLa) in 1 ml of lysis buffer [50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM ethylene diamine tetra-acetic (EDTA), 1 % Igepal (NP-40), 5 mM dithiothreitol (DTT) supplemented with protease and phosphatase inhibitors]. Clear lysate corresponding to approximately 1 mg of total protein was mixed with 50 l of each GST fusion containing beads and GST pull-downs were performed in a batch mode for 2 hours at 4 o C on a rotating wheel. GST pull-downs were subsequently washed three times with lysis buffer and/or high salt buffer [50 mM Tris-HCl pH 7.5, 500 mM NaCl, 1 mM ethylene diamine tetra-acetic (EDTA), 1 % Igepal (NP-40), 5 mM dithiothreitol (DTT) supplemented with protease and phosphatase inhibitors] and the beads were resuspended in 20 l of sample loading buffer.
Fig S10. Normal repair of SSB in
Cloning, Expression and Purification of aprataxin FHA domain and R29A and K38A mutants. Residues 1-105 of human aprataxin (NP_778243) were amplified by PCR using the 5'-CGGGATCCATGATGCGGGTGTGCTGGTTGG-3' and 5'-CCGCTCGAGTCA CTTTGCCTCTTCCTCAAACTCTAC-3' primers and cloned into pGEX-6P-1 (GE Healthcare). This cloning strategy leads to the addition of five amino acids (GPLGS) to the N terminus after cleavage with PreScission protease. The R29A and K38A mutant was generated using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). Constructs were transformed into E. coli BL21 (DE3) and protein expression was induced overnight at 18 o C by addition of 0.4 mM IPTG. Cells were lysed by sonication and clarified by centrifugation. The supernatant was applied to a glutathione-Sepharose resin (GE Healthcare) and fusion protein cleaved overnight by incubation with PreScission protease. Eluted protein was further purified by Superdex S75 (GE Healthcare) gel filtration chromatography. Wild-type FHA sequence in GFP-aprataxin construct was then replaced by a fragment containing the R29A and K38A mutations using restriction digestions. Presence of R29A and K38A mutations in the GST-FHA and GFP-aprataxin constructs was confirmed by DNA sequencing.
Nuclear H2AX foci analysis. For assessment of DSB repair kinetics we analysed the total nuclear volume for an average of 50-60 nuclei per time points and cell type. Briefly, cells were grown to confluence in 35mm Petri-dishes with 0.17 mm glass bottom. After treatment, cells were fixed in 4% paraformaldehyde / PBS for 10 min at room temperature and incubated in nuclear extraction buffer (10 mM PIPES pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 1 mM EGTA, 0.5% Triton X-100) at 55 rpm on a rotating shaker for 15 min. Non-specific binding was blocked by incubation with 5% FCS/PBS/0.1% Triton X-100 for 1h at RT. Immunostaining for MDC1 (sheep anti-
